While immunotherapy itself is not known to cause genetic mutations, it can lead to selective pressures that might result in the emergence of cancer cells with different mutations. These cells could potentially be more resistant to treatment. Ongoing research is focused on understanding these dynamics to improve the long-term effectiveness of immunotherapy.
